About this episode
On Monday, President Trump signed an executive order implementing a new prescription drug policy that he suggested could cut drug prices by 59 percent. At the signing, he emphasized the U.S. "will no longer tolerate profiteering and price gouging from Big Pharma." The government discovered this in 2022 per an HHS report, where researchers found that U.S. pharmaceutical companies typically charge two to three times more for prescription drugs than other developed nations. Food & Drug Administration Commissioner Dr. Marty Makary joins the Rundown to explain how the President's "most favored nation" drug pricing plan works and shares their "carrot and stick" approach to getting Big Pharma to cooperate on fair prices. Georgia lawmakers are already strategizing ahead of the 2026 midterm elections. With Democratic Senator Jon Ossoff already announcing his bid for a second term in the Senate earlier this year, several Republicans have stepped up to challenge the incumbent senator. One of the candidates is Georgia Congressman Buddy Carter. Rep. Carter joins the Rundown to share why he is the candidate to take on Senator Ossoff and later he gives his reaction to the Trump administration’s recent tariff deal with China. Plus, commentary from senior fellow at the American Enterprise Institute and author of “The Project,” Howard Husock. Photo Credit: AP Learn more about your ad choices. Visit podcastchoices.com/adchoices